Skip to content

Medical-device intelligence

Pharmacia Deutschland GmbH: FDA clearances and recalls

Research Pharmacia Deutschland GmbH in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

10 clearance records and 0 recall records in the covered releases, across 1 source company names and 5 product codes. Dated history runs from May 2, 2002 to Jul 2, 2004.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

10 matching records
Device / recordCompany in FDA recordSourceSource date
VARELISA PR3 ANCA, MODEL NUMBER 17748/17796K041043 · MOBPharmacia Deutschland GmbH510(k)Jul 2, 2004FDA decision date
VARELISA HISTONE ANTIBODIES, MODEL 16496K040810 · LJMPharmacia Deutschland GmbH510(k)May 14, 2004FDA decision date
VARELISA SSDNA ANTIBODIES, MODEL 14896K040811 · LRMPharmacia Deutschland GmbH510(k)May 13, 2004FDA decision date
VARELISA B2 GLYCOPROTEIN I IGG ANTIBODIES, MODELS 18748 AND 18796K040449 · MSVPharmacia Deutschland GmbH510(k)May 11, 2004FDA decision date
VARELISA B2 GLYCOPROTEIN I IGA ANTIBODIES, MODELS 18948 AND 18996K040450 · MSVPharmacia Deutschland GmbH510(k)May 11, 2004FDA decision date
VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896K040451 · MSVPharmacia Deutschland GmbH510(k)May 11, 2004FDA decision date
VARELISA B2 GLYCOPROTEIN I ANTIBODIES SCREEN, MODELS 19048 AND 19096K040452 · MSVPharmacia Deutschland GmbH510(k)May 11, 2004FDA decision date
VARELISA CARDIOLIPIN IGG ANTIBODIES, MODELS 15548 & 15596K020752 · MIDPharmacia Deutschland GmbH510(k)May 2, 2002FDA decision date
VARELISA CARDIOLIPIN IGA ANTIBODIES, MODELS 15748 & 15796K020757 · MIDPharmacia Deutschland GmbH510(k)May 2, 2002FDA decision date
VARELISA CARDIOLIPIN IGM ANTIBODIES, MODELS 15648 & 15696K020758 · MIDPharmacia Deutschland GmbH510(k)May 2, 2002FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗